PURPOSE: To describe the effect of unilateral intravitreal injection of 0.7-mg dexamethasone implant on the other eye. METHODS: Interventional case report and literature review. RESULTS: A 54-year-old woman with bilateral, refractory, clinically significant macular edema was given an intravitreal injection of 0.7-mg dexamethasone sustained release implant in the right eye. The central foveal thickness improved in both the eyes with recurrence of edema after 16 weeks in both the eyes. CONCLUSION: An intravitreal dexamethasone injection seems to have bilateral effect after unilateral injection.
PURPOSE: To describe the effect of unilateral intravitreal injection of 0.7-mg dexamethasone implant on the other eye. METHODS: Interventional case report and literature review. RESULTS: A 54-year-old woman with bilateral, refractory, clinically significant macular edema was given an intravitreal injection of 0.7-mg dexamethasone sustained release implant in the right eye. The central foveal thickness improved in both the eyes with recurrence of edema after 16 weeks in both the eyes. CONCLUSION: An intravitreal dexamethasone injection seems to have bilateral effect after unilateral injection.
Authors: Katarzyna Michalska-Małecka; Adam Kabiesz; Malgorzata W Kimsa; Barbara Strzałka-Mrozik; Maria Formińska-Kapuścik; Malgorzata Nita; Urszula Mazurek Journal: Clin Interv Aging Date: 2016-03-24 Impact factor: 4.458